mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
erastin |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
0.099 |
0.003 |
mRNA |
Bryostatin 1 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.004 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
-0.089 |
0.004 |
mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.004 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.005 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |